Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024
GlobeNewswire
*Allschwil, Switzerland – May 31, 2024*Idorsia Ltd (SIX: IDIA) today announced that data from the Phase 3 study of aprocitentan,..